Home Podcasts Dementia Matters
Dementia Matters

Dementia Matters

Wisconsin Alzheimer‘s Disease Research Center 236 Episodes Oct 6, 2026

Our podcast is here to help humanize Alzheimer’s disease, by speaking with the experts in our community to keep you informed on the latest headlines, research studies, and caregiver resources.

Episodes

Looking at More than Memory: Functional Assessments and Blood Tests for Alzheimer's Disease in Primary Care
Looking at More than Memory: Functional Assessments and Blood Tests for Alzheimer's Disease in Primary Care Oct 6, 2026 2906 Though new blood-based biomarker tests have made it less expensive, less invasive and more accessible to diagnose Alzheimer’s disease, they can’t replace the diagnostic process as a whole. Dr. Eric Widera joins the podcast to discuss the importance of assessing function when making a dementia diagnosis, what functional change can look like and how this kind of assessment can be incorporated into p
Examining Environmental Factors' Effects on Cognition
Examining Environmental Factors' Effects on Cognition Sep 22, 2026 2556 New research is looking at the effects of environmental factors on the brain as we age. Dr. Kathryn Conlon joins the podcast to discuss how factors like air pollution and lead exposure can affect cognition and overall brain health. She highlights how pollution affects both semantic and episodic memory as well as strategies for protecting brain health against these pollutants. Guest: Kathryn Conlo
Blood Tests and Brain Scans and Biomarkers, Oh My! How Biomarkers are Changing Alzheimer’s Disease Clinical Trials
Blood Tests and Brain Scans and Biomarkers, Oh My! How Biomarkers are Changing Alzheimer’s Disease Clinical Trials Sep 8, 2026 2721 In recent years, the U.S. Food and Drug Administration (FDA) has approved new biomarker tools for Alzheimer’s disease, including blood tests and tracers for brain scans. How are these tools used in research to help develop new Alzheimer’s treatments? Dr. Henrik Zetterberg returns to the podcast to discuss how blood tests, brain scans and other biomarker developments are transforming clinical trial
New Alzheimer’s Association Special Report Breaks Down How Americans Understand and Support their Brain Health
New Alzheimer’s Association Special Report Breaks Down How Americans Understand and Support their Brain Health Aug 25, 2026 2220 In recent years, public interest in brain health has increased. So how are Americans understanding brain health information and incorporating it into their own lives? This year, the Alzheimer’s Association released a special report focused on how people understand and support brain health throughout their lives, covering topics like how they perceive cognitive health, the importance of lifestyle b
Reflecting on 25 Years of the Wisconsin Registry for Alzheimer’s Prevention
Reflecting on 25 Years of the Wisconsin Registry for Alzheimer’s Prevention Aug 12, 2026 2154 Twenty-five years ago, a single participant enrolled in what would become the Wisconsin Registry for Alzheimer's Prevention (WRAP), now one of the largest and longest-running studies of Alzheimer's risk in the world. To celebrate this milestone, we’re joined by Dr. Mark Sager, who co-founded WRAP, along with current multi-principal investigators Dr. Sterling Johnson and Dr. Jessica Caldwell, to di
How Dementia Caregiving Affects the Spousal Caregiver
How Dementia Caregiving Affects the Spousal Caregiver Jul 28, 2026 2346 Caring for those with dementia represents a major public health challenge, with caregivers, especially spouses, providing long-term, largely unpaid care. With caregiving stress linked to a decline in mental and physical health, it is crucial to understand the complex burden these care partners face in order to  support them. Dr. Donna de Levante Raphael joins the podcast to shed light on the effec
Managing the Medicine Cabinet: How Prescriptions Impact Cognition and Brain Health as We Age
Managing the Medicine Cabinet: How Prescriptions Impact Cognition and Brain Health as We Age Jul 14, 2026 2104 Prescription medications, over-the-counter drugs and supplements are incredibly common among older adults, yet many of these routine treatments can unexpectedly impact cognitive function and brain health. To help us safely navigate medication management, Dr. Lauren Welch, a clinical geriatric pharmacy practitioner, joins the podcast to discuss how common drugs affect cognition, the risks of drug-d
Taking a Deep Dive into Subjective Cognitive Decline
Taking a Deep Dive into Subjective Cognitive Decline Jul 7, 2026 1024 Dr. Jessen returns to the podcast to take a deeper dive into subjective cognitive decline (SCD). Aiming to cover everything relating to SCD, Dr. Jessen shares insights in prognosis, risk factors and how SCD should be addressed in research and clinical practice.  Guest: Frank Jessen, MD, professor of psychiatry and psychotherapy, director, department of psychiatry, University of Cologne, clinical b
Defining Subjective Cognitive Decline
Defining Subjective Cognitive Decline Jun 30, 2026 1802 Subjective cognitive decline (SCD) can be one of the earliest noticeable signs of Alzheimer's disease, yet SCD is not yet fully understood. To help us understand more, Dr. Frank Jessen, an expert in the field, joins the podcast to discuss how SCD is defined, classified, and evaluated in both clinical and research settings. Guest: Frank Jessen, MD, professor of psychiatry and psychotherapy, directo
SPRINT to a Healthy Mind: How Blood Pressure Control Affects Brain Health and Dementia Risk
SPRINT to a Healthy Mind: How Blood Pressure Control Affects Brain Health and Dementia Risk Jun 18, 2026 2402 Geriatrician Dr. Mark Supiano joins the podcast to discuss the connection between heart and brain health. Citing multiple clinical trials, he breaks down what these studies and their findings mean for blood pressure management’s effect on cognitive decline and how they directly impact both patients and clinicians. Guest: Mark A. Supiano, MD, geriatrician, University Hospital Geriatrics Clinic, pro
Addressing Cochrane’s Review on Amyloid-Targeting Treatments for Alzheimer’s Disease
Addressing Cochrane’s Review on Amyloid-Targeting Treatments for Alzheimer’s Disease Jun 4, 2026 2654 Amyloid-targeting monoclonal antibody treatments have ushered in a new era of Alzheimer’s disease therapies after decades of research and clinical trials. A recent review published by Cochrane, a global, independent, non-profit network of researchers, professionals, patients and carers regarded as a gold standard for producing and promoting trusted, high-quality health information, has a different
What to Expect from ‘When Memory Fades’ with Drs. Art Walaszek and Nathaniel Chin
What to Expect from ‘When Memory Fades’ with Drs. Art Walaszek and Nathaniel Chin May 19, 2026 1976 Guest host Dr. Art Walaszek takes over the podcast to interview Dr. Chin about his upcoming book, When Memory Fades. In addition to discussing the importance of dementia research and other clinical topics covered in the book, Dr. Chin shares what drew him to write When Memory Fades, what the writing process was like, and what he hopes readers take away from his story. Guest host: Art Walaszek, MD,

Recommended